1 0

    FDA FCN 002035: Chemistry and Toxicology Review Memos and Correspondence

    FDA FCN 002035: Chemistry and Toxicology Review Memos and Correspondence

    $282.43 USD
    $282.43 USD
    Sale Sold out

    Contents: Deficiency Letter, Acknowledgement Letter, Final Letter, Memos, Chemistry Info, Toxicological data and risk assessment, Form FDA 3480, Form FDA 3480A, Submission Letter

    About: BASF Corporation’s Food Contact Notification FCN 2035, including all releasable FDA chemistry and toxicology review memoranda and all correspondence. FCN 2035 is for the use of octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate (CAS Reg. No. 2082-79-3) as an antioxidant/stabilizer in ethylene-methyl acrylate copolymer.

    126 Pages
    View full details
    FOIA Pro

    This drug has a lot more FDA history than one product page can show

    FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
    • Full-text search across every FDA FOIA log since 2020
    • Warning letters, approval records, and correspondence in one place
    • Monthly FDA FOIA Monitor newsletter, included
    • Cancel anytime, monthly or annual billing
    Get FOIA Pro
    Live search · FOIA database
    Searching related FDA records…
    ClosedTypeSubjectOutcome